[A bariatric surgery programme in adolescents. Preliminary results].

1. Michalski CW, Kleef J, Bachmann J, Al-Khatib J, Erkan M, Esposito I, et al. Second-look operation for unresectable pancreatic ductal adenocarcinoma at a high-volume center. Ann Surg Oncol. 2008;15:186–92. 2. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW. Curative resection is the most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91:586–94. 3. Sasson AR, Hoffman JP, Ross E, Kagan SA, Pigpank JF, Eisenberg BL. En bloc resection for locally advanced cancer of the pancreas: is it worthwile? J Gastrointest Surg. 2002;6:147–58. 4. Massucco P, Capussotti L, Magnino A, Sperti E, Gatti M, Muratore A, et al. Pancreatic resections after chemotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Ann Surg Oncol. 2006;13:1201–8. 5. Kim HJ, Czischke K, Brennan MF, Conlon KC. Does neoadyuvant chemoradiation downstage locally advanced pancreatic cancer? J Gastrointest Surg. 2002;6:763–9. 6. White RR, Hurwitz HI, Morse MA, Lee C, Anscher MS, Paulson EK, et al. Neoadyuvant chemoradiation for localiced adenocarcinoma of the pancreas. Ann Surg Oncol. 2001;8:758–65. 7. Ramacciato G, Mercantini P, Petrucciani N, Giaccaglia V, Nigri G, Ravaioli M. Does portal-superior mesenteric vein invasion still indicate irresecability for pancreatic carcinoma? Ann Surg Oncol. 2009;16:817–25. 8. Siriwardana HP, Siriwardena AK. Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg. 2006;93:662–73.